ECOR ElectroCore Inc

9,366

$5.57

$0.0267

(0.48%)

Today

Market Cap	$33.46M
Volume (M)	9,123.00
52-Wk High	$7.50
52-Wk Low	$3.10

ST Data

Watchers

New Watcher Rank

Fundamentals

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023Globe Newswire • 23 days ago

ROCKAWAY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company's Chief Medical...

Share to Feed

electroCore, Inc. (NASDAQ:ECOR) to Post FY2023 Earnings of ($3.50) Per Share, HC Wainwright ForecastsZolmax • 25 days ago

electroCore, Inc. (NASDAQ:ECOR Free Report) HC Wainwright reduced their FY2023 earnings per share (EPS) estimates for electroCore in a report released on Thursday, November 9th. HC...

electroCore price target raised to $11 from $10 at H.C. WainwrightThe Fly • 29 days ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Electrocore's Strong Q3 Results and Promising Future Prospects Justify 'Buy' Rating: A Comprehensive AnalysisTipRanks Financial Blog • 29 days ago

Ladenburg Thalmann & Co. analyst Jeffrey Cohen reiterated a Buy rating on Electrocore (ECOR Research Report) today and set a price target of $26...

electroCore, Inc. (ECOR) Q3 2023 Earnings Call TranscriptSeeking Alpha: Transcripts • 29 days ago

electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript...

electroCore (NASDAQ:ECOR) Given New $11.00 Price Target at HC WainwrightTicker Report • 29 days ago

electroCore (NASDAQ:ECOR Get Free Report) had its price target boosted by stock analysts at HC Wainwright from $10.00 to $11.00 in a note issued to investors on Thursday, Benzinga reports...

electroCore Announces Third Quarter 2023 Financial ResultsGlobe Newswire • about 1 month ago

Record third quarter 2023 net sales of $4.5 million, an increase of approximately 128% over third quarter 2022 Company increases revenue guidance for full year 2023 to $15.0 million - $15.5 million...

electroCore to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services ForumGlobe Newswire • about 1 month ago

ROCKAWAY, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger...

Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual MeetingGlobe Newswire • about 2 months ago

Clinical Trial suggests nVNS can reduce the use of rescue medications for exacerbations of nausea due to Gastroparesis or Functional Dyspepsia FIGURE 1 Primary Endpoint (n=35...

electroCore announces extension of gammaCore device listing in NHS Supply ChainThe Fly • about 2 months ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...